- Home
- ROIV vs CCK Comparison
ROIV vs CCK Comparison
Compare ROIV & CCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | CCK |
|---|---|---|
| Founded | 2014 | 1906 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Containers/Packaging |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 11.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ROIV | CCK |
|---|---|---|
| Price | $22.78 | $104.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 15 |
| Target Price | $24.31 | ★ $119.80 |
| AVG Volume (30 Days) | ★ 5.9M | 941.5K |
| Earning Date | 02-06-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 1.00% |
| EPS Growth | N/A | ★ 888.69 |
| EPS | N/A | ★ 8.10 |
| Revenue | $20,329,000.00 | ★ $12,141,000,000.00 |
| Revenue This Year | N/A | $4.80 |
| Revenue Next Year | $741.42 | $2.86 |
| P/E Ratio | ★ N/A | $12.83 |
| Revenue Growth | N/A | ★ 3.27 |
| 52 Week Low | $8.73 | $75.98 |
| 52 Week High | $23.91 | $109.48 |
Technical Indicators
Market Signals| Indicator | ROIV | CCK |
|---|---|---|
| Relative Strength Index (RSI) | 56.31 | 54.51 |
| Support Level | $22.50 | $102.95 |
| Resistance Level | $23.20 | $105.84 |
| Average True Range (ATR) | 0.75 | 2.32 |
| MACD | -0.01 | -0.33 |
| Stochastic Oscillator | 63.73 | 58.29 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About CCK Crown Holdings Inc.
Crown Holdings is one of the world's largest producers of metal packaging. The company manufactures beverage cans, metal food cans, and closures as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.